Clinical Trial Detail

NCT ID NCT03329001
Title Crossover Study to Assess the Relative Bioavailability of Niraparib Tablet Compared to Niraparib Capsule
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Tesaro, Inc.
Indications

Advanced Solid Tumor

Therapies

Niraparib

Age Groups: adult senior

No variant requirements are available.